Patent · US Active

Peptides and methods for the detection of lyme disease antibodies

US9766238B2 · kind B2 · utility

3Cited by
33References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 27, 2015
Grant dateSep 19, 2017
Priority date
Expiry dateOct 27, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention provides compositions (e.g., peptide compositions) useful for the detection of antibodies that bind to Borrelia antigens. The peptide compositions comprise polypeptide sequences comprising variants in the IR6 domain of the Borrelia VlsE protein. The invention also provides devices, methods, and kits comprising such peptide compositions and useful for the detection of antibodies that bind to Borrelia antigens and the diagnosis of Lyme disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.